These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6243169)

  • 21. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Converting enzyme inhibition: implications for renal perfusion and function.
    Hollenberg NK
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of essential hypertension.
    Stott DJ; Ball SG
    Br J Hosp Med; 1986 Oct; 36(4):261-2, 264-5, 268-9. PubMed ID: 2876740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hypertension in renal parenchymal diseases].
    Iversen BM; Kvam FI; Svarstad E
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2022-6. PubMed ID: 8766645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension].
    Salvetti A; Pedrinelli R; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Cardiologia; 1984; 29(1-2):103-20. PubMed ID: 6085475
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-modulating essential hypertension: renal hemodynamic effects of long-term angiotensin converting enzyme inhibition.
    Ramirez AJ; Migliorini M; Gilbert BH; Marco EJ; Sanchez RA
    J Hypertens Suppl; 1991 Dec; 9(6):S396-7. PubMed ID: 1819004
    [No Abstract]   [Full Text] [Related]  

  • 28. [Renal side effects of angiotensin converting enzyme inhibitors].
    Schmidt A; Mayer G
    Wien Med Wochenschr; 1996; 146(16):454-6. PubMed ID: 9036683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme inhibitor therapy of hypertension.
    Prosnitz EH
    Ariz Med; 1979 Apr; 36(4):286-8. PubMed ID: 220936
    [No Abstract]   [Full Text] [Related]  

  • 30. [Kidney protection by an ACE inhibitor].
    Mann J
    Fortschr Med Suppl; 1988; 52():5-6. PubMed ID: 2905336
    [No Abstract]   [Full Text] [Related]  

  • 31. [Angiotensin II inhibitors for the diagnosis and treatment of hypertension].
    Brunner HR; Gavras H
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1791-8. PubMed ID: 1013701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium channel blockers and angiotensin converting enzyme inhibitors in the treatment of high blood pressure].
    Koster M
    Ned Tijdschr Geneeskd; 1986 Aug; 130(34):1509-13. PubMed ID: 3020442
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
    Plante GE; Chainey A; Sirois P; Devissaguet M
    J Hypertens Suppl; 1988 Dec; 6(3):S69-73. PubMed ID: 3066878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic and therapeutic significance of antagonists of the renin-angiotensin system (author's transl)].
    Stumpe KO; Overlack A; Krück F
    Herz; 1978 Oct; 3(5):305-12. PubMed ID: 721057
    [No Abstract]   [Full Text] [Related]  

  • 35. [Are ACE inhibitors nephroprotective?].
    Hörl WH
    Wien Klin Wochenschr; 1996; 108(12):373-7. PubMed ID: 8767411
    [No Abstract]   [Full Text] [Related]  

  • 36. [Risk for hyperkalemia during long-term treatment with angiotensin-converting enzyme inhibitors in insulin-dependent type 2 diabetics in relation to the glomerular filtration rate].
    Raml A; Schmekal B; Grafinger P; Biesenbach G
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1327-30. PubMed ID: 11719857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension.
    Waller PC; McInnes GT
    Br Med J (Clin Res Ed); 1987 Mar; 294(6574):769. PubMed ID: 3032326
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversal of experimental acute cerebral vasospasm by angiotensin converting enzyme inhibition.
    Andrews P; Papadakis N; Gavras H
    Stroke; 1982; 13(4):480-3. PubMed ID: 6179264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged treatment of high-renin hypertension with a converting enzyme inhibitor.
    Vandenburg MJ; Sharman VL; Marsh FP; Rucinska EJ
    Br Med J; 1978 Sep; 2(6141):866. PubMed ID: 709099
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduction in hypertension-induced protein synthesis in the rat pulmonary trunk after treatment with teprotide (SQ 20881).
    McKenzie JC; Hung KS; Mattioli L; Klein RM
    Proc Soc Exp Biol Med; 1984 Nov; 177(2):377-82. PubMed ID: 6207542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.